Определение интерферона-гамма в тест-системах IGRA – значение в диагностике туберкулеза, в том числе у иммунокомпрометированных лиц

1. Пальцев М.А. (ред) Кожная проба с препаратом «ДИАСКИНТЕСТ» – новые возможности идентификации туберкулезной инфекции. // М.: ШИКО. – 2011. – 256 с.

2. Слогоцкая Л.В., Литвинов В.И., Филиппов А.В. и др. Чувствительность нового кожного теста «ДИАСКИНТЕСТ®» при туберкулезной инфекции у детей и подростков. // Пробл. туберкулеза и болезней легких. – 2010. – № 1. – С. 10-15.

3. Слогоцкая Л.В., Сенчихина О.Ю., Никитина Г.В., Богородская Е.М. Эффективность кожного теста с аллергеном туберкулезным рекомбинантным при выявлении туберкулеза у детей и подростков Москвы в 2013 г. // Педиатрическая фармакология. – 2015. – № 1. – С. 99-103.

4. Al-Orainey I. Diagnosis of latent tuberculosis: Can we do better? // Ann. Thorac. Med. – 2009. – Vol. 4. – N. 1. – P. 5-9.

5. Amicosante M., Ciccozzi M., Marcova R. Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies. // New Microbiol. – 2010. – Vol. 33. – N. 2. – P. 93-107.

6. Antonucci G., Girardi E., Raviglione M.C., Ippolito G. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. // JAMA. – 1995. – Vol. 274. – N. 2. – P. 143-148.

7. Bamford A.R., Crook A.M., Clark J.E. et al. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. // Arch. Dis. Child. – 2010. – Vol. 95. – N. 3. – P. 180–186.

8. Barry C., Boshoff H., Dartois V. et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. // Nat. Rev. Microbiol. – 2009. – Vol. 7. – N. 12. – P. 845–855.

9. Bendayan D., Hendler A., Litman K., Polansky V. The role of interferon-gamma release assays in the diagnosis of active tuberculosis. // Isr. Med. Assoc. J. – 2012. – Vol. 14. – N. 2. – P. 107–110.

10. Brock I., Weldingh K., Leyten E.M.R. et al. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. // J. Clin. Microbiol. – 2004. – Vol. 42. – N. 6. – P. 2379–2387.

11. Brouqui P., Delaique S., Parola P., Drancourt M. Interferon-gamma release assay: use and misuse. // Clin. Micriol. Infect. – 2012. – Vol. 18. – N. 11. – P. 1053-1054.

12. Bua A., Molicotti P., Cannas S. et al. Tuberculin skin test and QuantiFERON in children. // New Microbiol. – 2013. – Vol. 36. – N. 2. – P. 153-156.

13. Burman W.J., Jones B.E. Clinical and radiographic features of HIV-related tuberculosis. // Semin. Respir. Infect. – 2003. – Vol. 18. – N. 4. – P. 263-271.

14. Catanzaro A., Daley C. A summary of the Third Global Interferon-γ Release Assay Symposium. // Infect. Control. Hosp. Epidemiol. – 2013. – Vol. 34. – N. 6. – P. 619-624.

15. Cattamanchi A., Smith R., Steingart K. et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. // J. Acquir. Immune. Defic. Syndr. – 2011. – Vol. 56. – N. 3. – P. 230–238.

16. Chapman A., Munkanta M., Wilkinson K. et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. // AIDS. – 2002. – Vol. 16. – P. 2285-2293.

17. Cheallaigh C.N., Fitzgerald I., Grace J. et al. Interferon Gamma Release Assays for the diagnosis of latent tb infection in HIV-infected individuals in a low TB burden country. // PloS One. – 2013. – Vol. 8. – N. 1. – e53330.

18. Chee C., Barkham T., Khinmar K. et al. Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific in active and latent tuberculosis. // Eur. J. Clin. Microbiol. Infect. Dis. – 2009. – Vol. 28. – P. 667-670.

19. Chen J., Sun J., Zhang R. et al. T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency. // AIDS Res. Hum. Retroviruses. – 2011. – Vol. 27. – P. 289-294.

20. Chiappini E., Accetta G., Bonsiqnori F. et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis. // Int. J. Immunopathol. Pharmacol. – 2012. – Vol. 25. – N. 3. – P. 557–564.

21. Clark S., Martin S., Pozniak A. et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. // Clin. Exp. Immunol. – 2007. – Vol. 150. – N. 2. – P. 238-244.

22. Connell T.G., Zar H.J., Nicol M.P. Advances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected children. // J. Infect. Dis. – 2011. – Vol. 204. – N. 4. – P. 1151–1158.

23. Cruz A.T., Starke J.R. Pediatric tuberculosis. // Pediatr. Rev. – 2010. – Vol. 31. – N. 1. – P. 13-25.

24. Detjen A., Keil T., Roll S. et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. // Clin. Infect. Dis. – 2007. – Vol. 45. – P. 322-328.

25. Dheda K., Schwander S., Zhu B. et al. The immunology of tuberculosis: from bench to bedside. // Respirology. – 2010. – Vol. 15. – P. 433–450.

26. Diel R., Wrighton-Smith P., Zellweger J. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. // Eur. Respir. J. – 2007. – Vol. 30. – N. 2. – P. 321–332.

27. Diel R., Loddenkemper R., Meywald-Walter K. et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. // Am. J. Respir. Crit. Care Med. – 2008. – Vol. 177. – N. 10. – P. 1164–1170.

28. Diel R., Goletti D., Ferrara G. et al. Interferon-γ release assays in the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. // Eur. Respir. J. – 2011. – Vol. 37. – N. 1. – P. 88-99.

29. Doyle J.S., Bissessor M., Denhold J.T. et al. Latent Tuberculosis screening using interferon-gamma release assays an Australian HIV-infected cohort: is routine testing worthwhile? // J. Acquir. Immune. Defic. Syndr. – 2014. – Vol. 66. – N. 1. – P. 48-54.

30. European Centre for Disease Prevention and Control. Use of interferon-gamma release assays in support of TB diagnosis. Stockholm: ECDC; 2011.

31. Ewer K., Deeks J., Alvarez L. et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. // Lancet. – 2003. – Vol. 361. – N. 9364. – P. 1168-1173.

32. Ferrara G., Losi M., D’Amico R. et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. // Lancet. – 2006. – Vol. 367. – P. 1328–1334.

33. Fujita A., Ajisawa A., Harada N. et al. Performance of a whole-blood Interferon-Gamma Release Assay with Mycobacterium RD1-specific antigens among HIV-infected persons. // Clin. Dev. Immunol. – 2011. – Vol. 2011. – Article ID 325295.

34. Garcia G.F., Moura A.S., Ferreira C.S., Rocha M.O. Clinical and radiographic features of HIV-related pulmonary tuberculosis according to the level of immunosuppression. // Rev. Soc. Bras. Med. Trop. – 2007. – Vol. 40. – N. 6. – P. 622-626.

35. Ge L., Ma J.C., Han M. et al. Interferon-γ release assay for the diagnosis of latent Mycobacterium tuberculosis infection in children younger than 5 years: a meta-analysis. // Clin. Pediatr. – 2014. – Vol. 53. – N. 13. – P. 1255-1263.

36. Getahun H., Harrington M., O`Brien R., Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people HIV infection or AIDS in resource-constrained setting: informing urgent policy changes. // Lancet. – 2007. – Vol. 369. – N. 9578. – P. 2042-2049.

37. Glynn J.R., Murray J., Bester A. et al. Effect of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines. // AIDS. – 2008. – Vol. 22. – N. 14. – P. 1859-1867.

38. Grardon D., Erard V. Mycobacterium tuberculosis infection: signification, role and performance of measure of cell-mediated immune response. // Rev. Med. Suisse. – 2014. – Vol. 10. – N. 425. – P. 816-819.

39. Haustein T., Ridout D., Hartley J. et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. // Pediatr. Infect. Dis. J. – 2009. – Vol 28. – N. 8. – P. 669–673.

40. Janssens J., Roux-Lombard P., Perneger T. et al. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. // Eur. Respir. J. – 2007. – Vol. 30. – P. 722-728.

41. Kang Y., Lee H., Yoon H. et al. Discrepancy between the tuberculin skin test and the whole-blood interferon-gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis burden country. // JAMA. – 2005. – Vol. 293. – N. 22. – P. 2756-2771.

42. Kanunfre K., Leite O., Lopes M. et al. Enhancement of diagnostic efficiency by a gamma interferon release assay for pulmonary tuberculosis. // Clin.Vaccine Immunol. – 2008. – Vol. 15. – P. 1028-1030.

43. Kaplan J.E., Benson C., Holmes K.K. et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. // MMWR Recomm. Rep. – 2009. – Vol. 58 (RR-4). – P. 1-207.

44. Kunnath-Velayudhan S., Gennaro M. Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. // Clin. Microbiol. Rev. – 2011. – Vol. 24. – N. 4. – P. 792-805.

45. Lalvani A. Pathan A. Durkan H. et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigenspecific T cells. // Lancet. – 2001. – Vol. 357. – P. 2017-2021.

46. Lalvani A. Diagnosis tuberculosis infection in the 21st century: new tools to tackle an old enemy. // Chest. – 2007. – Vol. 131. – N. 6. – P. 1898-1906.

47. Lalvani A., Pareek M. A 100 year update on diagnosis of tuberculosis infection. // Br. Med. Bull. – 2010. – Vol. 93. – P. 69-84.

48. Lange C., Pai M., Drobniewski F., Migliori G. Interferon-gamma release assay for the diagnosis of active tuberculosis: sensible or silly? // Eur. Respir. J. – 2009. – Vol. 33. – N. 6 – P. 1250-1253.

49. Latorre I., De Souza-Galvao M., Ruiz-Manzano J. et al. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children. // Diagn. Microbiol. Infect. Dis. – 2009. – Vol. 65. – N. 3. – P. 236-246.

50. Latorre I., Martinez-Lacasa X., Font R. et al. IFN-γ response on T-cells based assays in HIV-infected patients for detection of tuberculosis infection. // BMC Infect. Dis. – 2010. – Vol. 10. – P. 348.

51. Lee J., Choi H., Park I. et al. Comparison of two commercial interferon-gamma assay for diagnosis Mycobacterium tuberculosis infection. // Eur. Respir. J. – 2006. – Vol. 28. – N. 1. – P. 24-30.

52. Lein A., von-Reyn C., Ravn P. et al. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium tuberculosis. // Clin. Diagn. Lab. – 1999. – Vol. 6. – P. 606-609.

53. Lewinsohn D.A., Gennaro M.L., Scholvinck L., Lewinsohn D. M. tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. // Int. J. Tuberc. Lung. Dis. – 2004. – Vol. 8. – N. 5. – P. 658-674.

54. Liebeschuetz S., Bamber S., Ewer K. et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. // Lancet. – 2004. – Vol. 364. – P. 2196-2203.

55. Ling D., Pai M., Davids V. et al. Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? // Eur. Respir. J. – 2011. – Vol. 38. – P. 649-656.

56. Ling D., Nicol M.P., Pai M. et al. Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis. // Torax. – 2013. – Vol. 68. – N. 9. – P. 860–866.

57. Machingaidze S., Wiysonge C.S., Gonzalez-Angulo Y. et al. The utility of an interferon-gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. // Pediatr. Infect. Dis. J. – 2011. – Vol. 30. – N. 8. – P. 694-700.

58. Mandalakas A., Hesseling A., Chegou N. et al. High level of discordant IGRA results in HIV-infected adults and children. // Int. J. Tuberc. Lung Dis. – 2008. – Vol. 12. – N. 4. – P. 417-423.

59. Mandalakas A.M., Detjen A.K., Hesseling A.C. et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. // Int. J. Tuberc. Lung Dis. – 2011. – Vol. 15. – N. 8. – P. 1018–1032.

60. Markova R., Drenska R., Minchev P. et al. Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis. // New Microbiol. – Vol. 34. – N. 1. – P. 81–85.

61. Mazurek G., Jereb J., Lobue P. et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection. United States. // MMWR Recomm. ReP. – 2005. – Vol. 16. – N. 54. – P. 49-55.

62. Mazurek G., Jereb J., Vernon A. et al. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection. // MMWR Recomm. Rep. – 2010. – Vol. 59. – P. 1-25.

63. Meier T., Eulenbruch H.P., Wriqhton-Smith P. et al. Sensitivity of a new commercial enzyme-linked immunospot assay (T.SPOT-TB) for diagnosis of tuberculosis in clinical practice. // Eur. J. Clin. Microbiol. Infect. Dis. – 2005. – Vol. 24. – N. 8. – P. 529–536.

64. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. // Ann. Intern. Med. – 2007. – Vol. 146. – P. 340-354.

65. Menzies D., Jahdali H.A., Otaibi B.A. Recent developments in treatment of latent tuberculosis infection. // Indian J. Med. Res. – 2011. – Vol. 133. – N. 3. – P. 257-266.

66. Metcalfe J., Everett C., Steingart K. et al. Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. // Clin. Infect. Dis. – 2011. – Vol. 204. – N. 15. – P. 1120-1129.

67. Mori T., Sakatani M., Yamagishi F. et al. Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens. // Am. J. Respir. Crit. Care Med. – 2004. – Vol. 170. – P. 59-64.

68. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2006.

69. Pai M., Riley L., Colford J. Jr Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. // Lancet Infect. Dis. – 2004. – Vol. 4. – N. 12. – P. 761–776.

70. Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. // Expert. Rev. Mol. Diagn. – 2006. – Vol. 6. – P. 413-422.

71. Pai M., O’Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? // PLoS One. – 2007. – Vol. 4. – N. 6. – e208.

72. Pai M., O’Brien R. New diagnostics for latent and active tuberculosis: state of the art and future prospects. // Semin. Respir. Crit. Care Med. – 2008. – Vol. 29. – P. 560–568.

73. Pai M., Zwerling A., Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. // Ann. Intern. Med. – 2008. – Vol. 149. – N. 3. – P. 177-184.

74. Pottumarthy S., Morris A.J., Harrison A.C., Wells V.C. Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test. // J. Clin. Microbiol. – 1999. – Vol. 37. – N. 10. – P. 3229–3232.

75. Pozniak A.L., Coyne K.M., Miller R.F. et al. British HIV Association guidelines for the treatment of TB/HIV coinfection 2011. // HIV Med. – 2011. – Vol. 12. – N. 9. – P. 517-524.

76. Raby E., Moyo M., Devendra A. et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis // PLoS One. – 2008. – Vol. 3. – N. 6. – e2489.

77. Rangaka M., Diwakar L., Seldon R. et al. Clinical, Immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. // Clin. Infect. Dis. – 2007. – Vol. 44. – P. 1639-1646.

78. Ravn P., Munk M., Andersen A. et al. Prospective evaluation of a whole blood test using mycobacterium tuberculosis specific antigen ESAT-6 and CFP-10 for diagnosis of active tuberculosis. // Clin. Diagn. Labor. Immunol. – 2005. – Vol. 12. – N. 4. – P. 491-496.

79. Richeldi L., Ewer K., Losi M. et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. // Ann. Intern. Med. – 2004. – Vol. 140. – N. 9. – P. 709-713.

80. Richeldi L. An update on the diagnosis of tuberculosis infection. // Am. J. Respir. Crit. Care Med. – 2006. – Vol. 174. – P. 736-742.

81. Sadatsafavi M., Shahidi N., Marra F. et al. A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy. // J. Clin. Epidemiol. – 2010. – Vol. 63. – N. 3. – P. 257–269.

82. Santin M., Munoz L., Rigau D. Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV- infected adults: a systematic review and meta-analysis. // PLoS One. – 2012. – Vol. 7. – N. 3. – e32482.

83. Schluger N., Burzynski J. Recent advances in testing for latent TB. // Chest. – 2010. – Vol. 138. – N. 6. – P. 1456-1463.

84. Schutz C., Meintjes G., Almajid F. et al. Clinical management of tuberculosis and HIV-1 co-infection. // Eur. Respir. J. – 2010. – Vol. 36. – N. 6. – P. 1460-1481.

85. Sester M., Giehl C., McNerney R. et al. Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. // Eur. Recpir. J. – 2010. – Vol. 36. – N. 6. – P. 1242-1247.

86. Sester M., Sotqiu G., Lanqe C. et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. // Eur. Respir. J. – 2011. – Vol. 37. – N. 1. – P. 100-111.

87. Simpson T., Tomaro J., Jobb C. Implementation of an interferon-gamma release assay to screen for tuberculosis in refugees and immigrants. // J. Immigr. Minor. Health. – 2013. – Vol. 15. – N. 4. – P.686-692.

88. Sonnenberg P., Glynn J., Fielding K. et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. // J. Infect. Dis. – 2005. – Vol. 191. – N. 2. – P. 150-158.

89. Souza J.M., Evangelista M.S., Trajman A. Added value of QuantiFERON TB-gold in tube for detecting latent tuberculosis among persons living with HIV/AIDS. // Biomed. Rec. Int. – 2014. – Vol. 2014. – Article ID 294963.

90. Starke J.R. New concepts in childhood tuberculosis. // Curr. Opin. Pediatr. – 2007. – Vol. 19. – N. 3. – P. 306-313.

91. Starke J.R. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children. // Pediatrics. – 2014. – Vol. 134. – N. 6. – P. 1763-1773.

92. Stephan C., Wolf T., Goetsch U. et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. // AIDS. – 2008. – Vol. 22. – N. 18. – P. 2471-2479.

93. Streeton J., Desem N., Jones S. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. // Int. J. Tuberc. Lung Dis. – 1998. – Vol. 2. – P. 443-450.

94. Sun L., Xiao J., Miao Q. et al. Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis. // FEMS Immunol. Med. Microbiol. – 2011. – Vol. 63. – N. 2. – P. 165–173.

95. Tan C.K., Hung C.C., Lai C.C. et al. Diagnosis of active tuberculosis by enzyme-linked immunospot assay for interferon-gamma in HIV-infected patients. // J. Acquir. Immune Defic. Syndr. – 2010. – Vol. 53. – N. 4. – P. 546-547.

96. Wallis R., Pai M., Menzies D. et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. // Lancet. – 2010. – Vol. 375. – P. 1920–1937.

97. Walzl G., Ronacher K., Hanekom W. et al. Immunological biomarkers of tuberculosis. // Nat. Rev. Immunol. – 2011. – Vol. 11. – N. 5. – P. 343-354.

98. Wang S., Powell D., Nagaraja H. et al. Evaluation of a modified interferon-gamma release assay for the diagnosis of latent tuberculosis infection in adult and paediatric populations that enables delayed processing. // Scand. J. Infect. Dis. – 2010. – Vol. 42. – N. 11-12. – P. 845-850.

99. Weinfurter P., Blumberg H.M., Goldbaum G. et al. Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups. // Int. J. Tuberc. Lung Dis. – 2011. – Vol. 15. – N. 8. – P. 1056-1061.

100. WHO. World Health Organization website. Available: http://whqlibdoc.who.int/publications/2011/9789241564380_eng.pdf. Accessed 2011 September 22.

101. Winthrop K.L., Weinblatt M.E., Daley C.L. You can’t always get what you want, but if you try sometimes (with two tests – TST and IGRA – for tuberculosis) you get what you need. //Ann. Rheum. Dis. – 2012. – Vol. 71. – N. 11. – P. 1757-1760.

102. Wrighton-Smith P., Zellweger J. Direct costs of three models for the screening of latent tuberculosis infection. // Eur. Respir. J. – 2006. – Vol. 28. – P. 45-50.

103. Yates F., Janakiraman A., Headly A. et al. Attitudes towards latent tuberculosis among physicians in training: the role of BCG vaccination. // J. Community. Health. – 2015. – Vol. 40. – N. 2. – P.364-366.